DHFR and acute lymphoblastic leukemia: DHFR is also an established drug target, with methotrexate being one of the most widely used DHFR inhibitors that is still in clinical use for the treatment of rheumatoid arthritis and acute lymphoblastic leukemia.9, 10, 11, 12, 13